B‐cell activating factor receptor expression in B‐lymphoblastic leukaemia: Flow cytometric analysis and implications for targeted therapy
Parastou Tizro, Ibrahim Aldoss, Xiuli Wang, Larry W. Kwak et autres
0 citationsBritish Journal of Haematology
Lihua E. Budde
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
363Publications signalées
8695Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchMonoclonal and Polyclonal Antibodies ResearchCutaneous lymphoproliferative disorders research
Publications récentes
CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission
Ibrahim Aldoss, Lior Goldberg, Jianying Zhang, Andrew Artz et autres
1 citationBlood Advances
Supplementary Table S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S4 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Table S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S5 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S3 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S6 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Supplementary Figure S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, Michael E. Hurwitz et autres
0 citations
Mosunetuzumab plus polatuzumab vedotin for relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study
Lihua E. Budde, Manali Kamdar, Sarit Assouline, Julio C. Chávez et autres
5 citationsBlood
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial
Paolo Strati, Lori A. Leslie, Parveen Shiraz, Lihua E. Budde et autres
1 citationNature Cancer
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.